Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Kenneth Ataga, MD
Researcher Director
Division of Hematology/Oncology
University of Tennessee Health Science Center
956 Court Avenue
D324 Coleman Building
Memphis, Tennessee, United States
Dr. Ataga’s clinical interest is in classical hematology and hemoglobinopathies. He is the Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) at Memphis. His clinical research is focused on the vasculopathy of sickle cell disease, with an emphasis on pulmonary hypertension and renal complications, and coagulation activation in sickle cell disease. In addition, Dr. Ataga has a strong research interest in the development of new therapies for sickle cell disease. He conducts clinical trials in sickle cell disease funded by the National Institutes of Health and the Pharmaceutical Industry.
Representative Publications:
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Pharmacologic Therapies for Sickle Cell Disease
Related Content
-
Julie A. Panepinto, MD, MSPHJulie Panepinto is the Director of the D...
-
The 2020 ASPHO Conference – CANCELEDMore than 1,200 pediatric hematology/onc...
-
Aisha Walker, PhDDr. Walker is a Research Assistant Profe...
-
Disability evaluation under social security (hematological disorders – childhood)A. What hematological disorders do we ev...
-
2019 WEPSCF Rockin’ the Red – 14th Annual FundraiserJoin us as we celebrate National Sickle ...
-
Dental Health in Children with Sickle Cell DiseaseWhat is Sickle Cell Disease? Sickle Cel...
-
Virginia Commonwealth University, Massey Cancer CenterVCU Massey Cancer Center is among the to...